Literature DB >> 9145740

Association of antibodies to Chlamydia trachomatis heat-shock protein 60 kD with chronic nongonococcal urethritis.

P J Horner1, D Cain, M McClure, B J Thomas, C Gilroy, M Ali, J N Weber, D Taylor-Robinson.   

Abstract

Ninety male patients with acute nongonococcal urethritis (NGU) who presented for follow-up 10-92 days after initiation of treatment were evaluated. A polymerase chain reaction assay and direct fluorescence antibody test were used to detect Chlamydia trachomatis at presentation and during follow-up. Chlamydial heat-shock protein 60 kD (hsp60) serology with an enzyme-linked immunosorbent assay and C. trachomatis serology with a microimmunofluoresence test were undertaken. In 62 (69%) of the men, evidence of chronic urethritis was noted during follow-up. C. trachomatis was detected in only two patients during follow-up. Chlamydial hsp60 antibody was associated with the development of chronic urethritis between 10 and 92 days after treatment began (P < .04), that is, at 10-29 days (P < .02) and at 30-92 days (P < .008). These results are consistent with the theory that immune response to hsp60 is important in the development of this chronic disease. The results also suggest that chronic NGU is not a consequence of continued production of hsp60 by C. trachomatis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145740     DOI: 10.1093/clind/24.4.653

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Chlamydia pneumoniae GroEL1 protein is cell surface associated and required for infection of HEp-2 cells.

Authors:  Frederik N Wuppermann; Katja Mölleken; Marion Julien; Christian A Jantos; Johannes H Hegemann
Journal:  J Bacteriol       Date:  2008-02-29       Impact factor: 3.490

2.  Peripheral blood T cell proliferative response to chlamydial organisms in gonococcal and non-gonococcal urethritis and presumed pelvic inflammatory disease.

Authors:  M Shahmanesh; M Brunst; A Sukthankar; J H Pearce; J S Gaston
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

Review 3.  Concurrent gonococcal and chlamydial infection: how best to treat.

Authors:  A J Robinson; G L Ridgway
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

4.  Meningococcal porin PorB prevents cellular apoptosis in a toll-like receptor 2- and NF-kappaB-independent manner.

Authors:  Paola Massari; Jay Gunawardana; Xiuping Liu; Lee M Wetzler
Journal:  Infect Immun       Date:  2009-12-22       Impact factor: 3.441

Review 5.  What Can Serology Tell Us About the Burden of Infertility in Women Caused by Chlamydia?

Authors:  Patrick J Horner; Gloria E Anyalechi; William M Geisler
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 5.226

6.  Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection.

Authors:  Gillian S Wills; Patrick J Horner; Rosy Reynolds; Anne M Johnson; David A Muir; David W Brown; Alan Winston; Andrew J Broadbent; David Parker; Myra O McClure
Journal:  Clin Vaccine Immunol       Date:  2009-04-08

7.  Isolation and characterisation of T lymphocytes from the urethra of patients with acute urethritis.

Authors:  M Brunst; M Shahmanesh; A Sukthankar; J H Pearce; J S Gaston
Journal:  Sex Transm Infect       Date:  1998-08       Impact factor: 3.519

Review 8.  Heat shock protein expression and immunity in chlamydial infections.

Authors:  R W Peeling; D C Mabey
Journal:  Infect Dis Obstet Gynecol       Date:  1999

9.  Incidence of Nongonococcal Urethritis in Men Who Have Sex With Women and Associated Risk Factors.

Authors:  Emily Rowlinson; James P Hughes; Laura C Chambers; M Sylvan Lowens; Jennifer L Morgan; Tashina S Robinson; Sarah S Romano; Gina L Leipertz; Olusegun O Soge; Matthew R Golden; Lisa E Manhart
Journal:  Sex Transm Dis       Date:  2021-05-01       Impact factor: 2.830

Review 10.  Management of non-gonococcal urethritis.

Authors:  Harald Moi; Karla Blee; Patrick J Horner
Journal:  BMC Infect Dis       Date:  2015-07-29       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.